The need for continued education is critical in these uncertain times. Therefore, the co-directors of the Fall Clinical Dermatology Conference are excited to announce our new program: the Fall Clinical Virtual Grand Rounds (FCVGR). This new online series is designed to help maintain the educational opportunities one would have if they were able to attend grand rounds in person.

FCVGR will consist of weekly CME sessions on a variety of dermatological diseases and tools.

This week, we will be coming to you LIVE!
Wednesday, September 16, 2020
8 PM EDT/ 5 PM PDT

EVOLVING CONCEPTS IN DERMATOLOGY PART XVI

Office Tips: Therapeutic Pearls

Safety and Efficacy of Botanicals to Enhance Photoprotection

What Do Androgen Receptors Have To Do With Acne Treatment?

Log in to Begin Activity

James Del Rosso, DO

Faculty

Adjunct Clinical Professor (Dermatology)
Touro University College of Osteopathic Medicine
Henderson, NV

Seemal Desai, MD

Faculty

Clinical Assistant Professor
Department of Dermatology
University of Texas Southwestern Medical Center
Dallas, TX

Mark Lebwohl, MD

Faculty

Dean for Clinical Therapeutics
Waldman Professor and Chairman
Kimberly and Eric J. Waldman Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY

Upon completion of this activity, the participant should be better able to:

Recognize various clinical conditions for which isotretinoin can be helpful
Understand the role of androgens and androgen receptors and the clinical implications for acne treatment
Discuss the safety and efficacy of botanicals to enhance photoprotection

This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and Dermatology University. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

The Institute designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by educational grants from Almirall, Bristol-Myers Squibb, Lilly, Mayne Pharma, and UCB.

CONFLICTS OF INTEREST/DISCLOSURES

James Del Rosso, DO

Consultant: Aclaris, Almirall, BioPharmX, Cassiopea, Celgene, Cutanea, Dermira, Encore, EPI Health, Ferndale, Foamix, Galderma, LEO LaRoche-Posay, Menlo Therapeutics, Novan, Ortho Dermatologics, Pfizer, Promius, Sanofi/Genzyme, Sonoma (Intraderm), Sol Gel, Sun Pharma, Verrica

Grant/Research Support: Abbvie, Aclaris, Almirall. Athenex, BioPharmX, Botanix, Celgene, Dermira, Foamix, Galderma, Genentech, LEO, Menlo Therapeutics, Novan, Ortho Dermatologics, Promius, Regeneron, Sanofi/Genzyme Sol Gel, Sun Pharma

Speakers’ Bureau or Honoraria: Aclaris, Almirall, Celgene, Cutane, Dermira, Encore, EPI Health, Galderma, Genetech, LEO, Ortho Dermatologics, Pfizer, Promius, Regeneron, Sanofi/Genzyme, Sol Gel, Sun Pharma, Verrica

Seemal Desai, MD

Consultant/Independent Contractor: Abbvie Inc., Dermavant Sciences, Inc., Novan, SkinMedica, Symbio, Watson

Grant/Research Support: Dermavant Sciences, Inc., Menlo, Pfizer, Skinceutical

Speakers Bureau: Pfizer, Skinceuticals

Mark Lebwohl, MD

Consultant: Allergan, Almirall, Arcutis, Avotres Therapeutics, BirchBioMed, Boehringer-Ingelheim, Bristol-Myers Squibb, Cora therapeutics, Castle Biosciences, Corrona, Dermavant Sciences, Foundation for Research and Education in Dermatology, Inozyme Pharma, LEO, meiji Seika Pharma, Menlo, Mitsubishi, Neuroderm, Pfizer, Promius/ Dr. Reddy’s abs, Theravance, Verrica

Grant/Research Support: Abbvie, Amgen, Arcutis, AstraZeneca, Boehringer Ingelheim, Celgene, Clinuvel, Eli Lilly, Incyte, Janssen Research & Development, Kadmon Corp., LEO, Medimmune, Novartis, Ortho Dermatologics, Pfizer, Sciderm UCB, ViDac

Cathy Pagano (Institute for Continuing Healthcare Education) has disclosed that she has no relevant financial relationships specific to the subject matter within the past 12 months.

Session 19 Evolving Concepts in Dermatology Part XVI

James Del Rosso, DO

Seemal Desai, MD

Mark Lebwohl, MD

CONFLICTS OF INTEREST/DISCLOSURES

Session 19
Evolving Concepts in Dermatology Part XVI